Naomi Kiyota

39PUBLICATIONS
183CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersPacific Peoples remote health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Aug 03, 2026
Darolutamide Alone and in Combination With Goserelin in Androgen Receptor-Positive Salivary Gland Carcinoma: Results From the Phase II DISCOVARY Trial.

|Jul 31, 2026
Encorafenib plus binimetinib for BRAF V600-mutated thyroid cancer in Japan: final analysis.

|Jun 26, 2026
Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck Cancer.

|Jun 24, 2026
A multicenter randomized phase III trial of weekly cisplatin chemoradiotherapy versus radiotherapy in elderly patients with head and neck squamous cell carcinoma unfit for high-dose cisplatin: JCOG2405 (ELDER-WEEKLY).

|Jun 22, 2026
Current status and future perspectives of treatment de-escalation in localized head and neck cancer.

|Apr 13, 2026
Non-surgical definitive treatment and geriatric assessment in older patients with locally advanced head and neck cancer.

Koichi Yasuda, Yoshitaka Honma, Yuri Ueda

Pageof 7

Frequent Collaborators

8 joint publications

Makoto Tahara

6 joint publications

Nobuhiro Hanai

6 joint publications

Johanna Inhestern

6 joint publications

Susanne Singer